NCT Number: NCT03901560
Music Therapy: Sickle Cell and Pain Crisis
This study will assess whether participants who receive music therapy during inpatient care report a decrease in pain and whether music therapy influences factors such as family satisfaction.
Looking for future studies?
Notify MeKey information
Conditions
Age range
5 year–17 year
Sex eligibility
All sexes
Study type
Observational
About this study
The purpose of this study is to determine if music therapy services can serve as a viable, necessary, and beneficial aspect of inpatient pain management, distraction, and coping for pediatric patients in the acute care hospital setting. The investigator will note the effect of music therapy services in conjunction with pain scores reported by the participant and an increase in self and family reported coping skills during hospitalization.
Participants will be referred by providers from pain management service, oncology/hematology service, or the gastrointestinal (GI) service for functional and abdominal pain. Participants who meet the criteria for inclusion will be selected. The study will be explained to parents and a consent form will be left for the family to review and sign at their convenience. Participants will provide a pain scale level and vitals before completing the music therapy intervention. Once the music therapy intervention is completed, the pain scale and vitals will be repeated.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 5-17 years of age
- Admitted for sickle cell crisis, functional abdominal pain, or whom the pediatric pain management team is following.
Exclusion criteria
- Non-English speaking
- Under 5 years old and over 17 years old
- Patients who are unable to hear or have a hearing disability
- Developmentally unable to self-report pain levels
Treatment and study plan
Primary outcomes
-
How does music therapy affect perceived pain in hospitalized pediatric patients?
Time frame: 30 minutes
Do pediatric patients who receive music therapy report a decrease in pain after receiving a music therapy intervention as measured by the Wong Baker Faces Scale? The Wong Baker Faces Scale uses six different faces to assist child patients in rating their pain on a scale of '0' for no pain to '10' for severe to extreme pain.
-
How does music therapy influence factors such as family satisfaction and length of stay at the time of discharge?
Time frame: 30 minutes
Will music therapy result in patient and/or family satisfaction as measured by a survey administered immediately after the intervention?
Sponsors and collaborators
Lead sponsor
University of Oklahoma
Other
Collaborators
- The Children's Hospital at OU Medical Center
Registry information
Official study title
The Effect of Music Therapy on Pediatric Patients Admitted to the Hospital for Sickle Cell or Pain Crisis
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Apr 3, 2019
- Registry last updated
- Apr 5, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients
NCT03431285
Anemia, Anemia, Hemolytic
Dammam, Eastern Province, Saudi Arabia
View Trial DetailsVirtual Reality as an Adjuvant Therapy for Sickle Cell Vaso-Occlusive Crisis in the Pediatric Emergency Department
NCT05864092
Anemia, Anemia, Hemolytic
Jackson, Mississippi, United States
View Trial DetailsMindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease
NCT05572294
Anemia, Anemia, Hemolytic
Dallas, Texas, United States
View Trial DetailsTransillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)
NCT03477552
Anemia, Anemia, Hemolytic
Créteil, France
View Trial Details